Philip Y. Lam

1.1k total citations
28 papers, 878 citations indexed

About

Philip Y. Lam is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Complementary and alternative medicine. According to data from OpenAlex, Philip Y. Lam has authored 28 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Pathology and Forensic Medicine and 5 papers in Complementary and alternative medicine. Recurrent topics in Philip Y. Lam's work include Mitochondrial Function and Pathology (7 papers), Plant-derived Lignans Synthesis and Bioactivity (6 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Philip Y. Lam is often cited by papers focused on Mitochondrial Function and Pathology (7 papers), Plant-derived Lignans Synthesis and Bioactivity (6 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). Philip Y. Lam collaborates with scholars based in Hong Kong, United States and Canada. Philip Y. Lam's co-authors include Enrique Cadenas, Derick Han, Qiongqiong Zhou, Kam Ming Ko, Po Yee Chiu, Stan G. Louie, Kevin J. Gaffney, Thomas C. Chen, Adel Kardosh and Encouse B. Golden and has published in prestigious journals such as Blood, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Philip Y. Lam

28 papers receiving 844 citations

Peers

Philip Y. Lam

CAM

PFM

PHYSI

ONCOL

Xuanxuan Zhou China

Shan Miao China

Shinjiro Kobayashi Japan

Eun Sun Yang South Korea

Wenpeng Dong China

Mi‐Young Jeong South Korea

Hanping Qi China

Jeong Seon Yoon South Korea

Liuyi Dong China

Haibo Zhu China

Xuanxuan Zhou China

Philip Y. Lam

496 ×1.0

187 ×1.5

CAM

118 ×0.9

PFM

94 ×0.8

PHYSI

41 ×0.5

ONCOL

Citations per year, relative to Philip Y. Lam Philip Y. Lam (= 1×) peers Xuanxuan Zhou

Countries citing papers authored by Philip Y. Lam

Since Specialization

Citations

This map shows the geographic impact of Philip Y. Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Y. Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Y. Lam more than expected).

Fields of papers citing papers by Philip Y. Lam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Y. Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Y. Lam. The network helps show where Philip Y. Lam may publish in the future.

Co-authorship network of co-authors of Philip Y. Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Y. Lam. A scholar is included among the top collaborators of Philip Y. Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Y. Lam. Philip Y. Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomsen, Noel M., G.J. O'Brien, Carina C. Sanchez, et al.. (2024). Discovery and Optimization of First-in-Class Molecular Glue Degraders of the WIZ Transcription Factor for Fetal Hemoglobin Induction to Treat Sickle Cell Disease. Journal of Medicinal Chemistry. 67(22). 20682–20694. 4 indexed citations

Lam, Philip Y. & Kam Ming Ko. (2012). Beneficial effect of (–)Schisandrin B against 3‐nitropropionic acid‐induced cell death in PC12 cells. BioFactors. 38(3). 219–225. 11 indexed citations

Lam, Philip Y., Hoi Shan Wong, Jihang Chen, & Kam Ming Ko. (2012). A Hypothetical Anti-Aging Mechanism of “Yang-Invigorating” Chinese Tonic Herbs. Chinese Medicine. 3(1). 72–78. 1 indexed citations

Lam, Philip Y. & Kam Ming Ko. (2012). Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases. Oxidative Medicine and Cellular Longevity. 2012. 1–9. 30 indexed citations

Chiu, Po Yee, et al.. (2011). Schisandrin B protects against solar irradiation-induced oxidative injury in BJ human fibroblasts. Fitoterapia. 82(4). 682–691. 23 indexed citations

Chiu, Po Yee, Hoi Yan Leung, Pou Kuan Leong, et al.. (2011). Acute treatment with Danshen–Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKCɛ/mKATP pathway in rats. Phytomedicine. 18(11). 916–925. 19 indexed citations

Lam, Philip Y., Pou Kuan Leong, Na Chen, & Kam Ming Ko. (2011). Schisandrin B enhances the glutathione redox cycling and protects against oxidant injury in different types of cultured cells. BioFactors. 37(6). 439–446. 14 indexed citations

Chiu, Po Yee, Hoi Yan Leung, Limin Zhou, et al.. (2011). Myocardial post-conditioning with Danshen-Gegen decoction protects against isoproterenol-induced myocardial injury via a PKCε/mKATP-mediated pathway in rats. Chinese Medicine. 6(1). 7–7. 15 indexed citations

Chiu, Po Yee, Hoi Yan Leung, Pou Kuan Leong, et al.. (2011). Danshen–Gegen decoction protects against hypoxia/reoxygenation-induced apoptosis by inhibiting mitochondrial permeability transition via the redox-sensitive ERK/Nrf2 and PKCɛ/mKATP pathways in H9c2 cardiomyocytes. Phytomedicine. 19(2). 99–110. 18 indexed citations

10.

Lam, Philip Y., et al.. (2010). Schisandrin B protects against solar irradiation-induced oxidative stress in rat skin tissue. Fitoterapia. 82(3). 393–400. 25 indexed citations

11.

Lam, Philip Y., Po Yee Chiu, Hoi Yan Leung, et al.. (2010). Schisandrin B co-treatment ameliorates the impairment on mitochondrial antioxidant status in various tissues of long-term ethanol treated rats. Fitoterapia. 81(8). 1239–1245. 15 indexed citations

12.

Zhou, Qiongqiong, Philip Y. Lam, Derick Han, & Enrique Cadenas. (2009). Activation of c‐Jun‐N‐terminal kinase and decline of mitochondrial pyruvate dehydrogenase activity during brain aging. FEBS Letters. 583(7). 1132–1140. 66 indexed citations

13.

Lam, Philip Y., Fei Yin, Ryan T. Hamilton, A Boveris, & Enrique Cadenas. (2009). Elevated neuronal nitric oxide synthase expression during ageing and mitochondrial energy production. Free Radical Research. 43(5). 431–439. 38 indexed citations

14.

Arciuch, Valeria G. Antico, Soledad Galli, María Clara Franco, et al.. (2009). Akt1 Intramitochondrial Cycling Is a Crucial Step in the Redox Modulation of Cell Cycle Progression. PLoS ONE. 4(10). e7523–e7523. 64 indexed citations

15.

Zhou, Qiongqiong, Philip Y. Lam, Derick Han, & Enrique Cadenas. (2007). c‐Jun N‐terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons. Journal of Neurochemistry. 104(2). 325–335. 97 indexed citations

16.

Lam, Philip Y., Kai Chen, & Jean C. Shih. (2004). The circadian rhythm of 5-HT biosynthetic and degradative enzymes in immortalized mouse neuroendocrine pineal cell line–a model for studying circadian rhythm. Life Sciences. 75(25). 3017–3026. 1 indexed citations

17.

Yu, Albert Cheung Hoi, et al.. (2002). Changes of ATP and ADP in Cultured Astrocytes Under and After in Vitro Ischemia. Neurochemical Research. 27(12). 1663–1668. 22 indexed citations

18.

Zhang, Yun, et al.. (2002). Activation of Erk1/2 and Akt in astrocytes under ischemia. Biochemical and Biophysical Research Communications. 294(3). 726–733. 63 indexed citations

19.

Davies, E. Rhys, Miyoko Takahashi, Philip Y. Lam, et al.. (1997). Analytical Performance and Clinical Utility of a Sensitive Immunoassay for Determination of Human Cardiac Troponin I. Clinical Biochemistry. 30(6). 479–490. 36 indexed citations

20.

Dosch, Hans-Michael, et al.. (1988). Activation of human B lymphocytes by 8′ substituted guanosine derivatives. Immunology Letters. 17(2). 125–131. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact